Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:14 PM
Ignite Modification Date:
2025-12-24 @ 9:14 PM
NCT ID:
NCT05808504
Eligibility Criteria:
Inclusion Criteria:
For all participants:
* Affiliation to a social security scheme or beneficiary of such a scheme.
* Age over 18 years old.
* Age less than 75 years old
* Correct or correctly corrected view (on simple declaration by the patient).
* Subject having received information on the protocol and having provided informed and written consent to participate.
Criteria exclusive to patients:
\- Idiopathic Parkinson's disease according to United Kingdom Parkinson's criteria Brain Bank disease (Hughes et al., 1992).
Exclusion Criteria:
For all participants:
* Major cognitive impairment (Moca \< 22) or severe neurocognitive disorder according to DSM-V (Diagnostic and statistical manual of mental disorders -V);
* Motor difficulties preventing the achievement of the task.
* Drug or alcohol addiction.
* Adult subject to legal protection (safeguard of justice, curatorship, guardianship), persons deprived of liberty.
* Present or past moderate to severe psychiatric pathology (obsessive compulsive, bipolar disorder, schizophrenia, etc.).
* Potential for pregnancy or confirmed pregnancy. A pregnancy test will be performed on inclusion.for women of childbearing age.
Criteria exclusive to patients:
* Present or past neurological pathology other than Parkinson's disease (accident stroke, head trauma, etc.).
* Deep brain stimulation treatment.
Exclusive to healthy participants:
\- Present or past neurological pathology.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT05808504
Study Brief:
Protocol Section:
NCT05808504